Ozempic Dosage FAQs, Answered
Ozempic dosage follows a fixed step-up schedule: 0.25 mg once weekly for four weeks, then 0.5 mg weekly, with increases to 1 mg and then 2 mg as needed, each held for at least four weeks. The 0.25 mg start is a warm-up dose, not a treatment dose. The schedule exists to blunt nausea, and the label caps Ozempic at 2 mg per week. Most of the confusion around dosing comes from mixing Ozempic up with Wegovy, which is a different product.
What does the standard titration actually look like?
The OZEMPIC prescribing information sets a clear ladder. Weeks one through four use 0.25 mg once weekly. That amount is not expected to lower blood sugar much on its own; it is there to let the gut adjust. At week five the dose moves to 0.5 mg weekly. If more effect is needed after at least four weeks, it can rise to 1 mg, and then, again after four weeks, to a maximum of 2 mg. None of these steps are meant to be rushed.
The reason for the slow climb is practical. Semaglutide slows stomach emptying and acts on appetite and glucose signaling, and those same mechanisms produce nausea, vomiting, and loose stools when the dose jumps too fast. A review of how these drugs work describes the receptor activity that drives both the benefit and the digestive side effects, which is why the label treats early doses as tolerability steps rather than full doses.
Is Ozempic the same as Wegovy?
They share one molecule, semaglutide, but they are separate approved products with separate dosing. Ozempic is approved for type 2 diabetes and stops at 2 mg weekly. Wegovy is approved for chronic weight management and titrates on its own schedule up to 2.4 mg weekly. The FDA has publicly addressed the overlap and the safety questions that come with it in its notice on medications containing semaglutide, which is worth reading if the two names keep getting tangled.
This matters for anyone comparing an Ozempic dose against what they have read about weight loss. The largest weight-loss trials, such as STEP 3 and STEP 8, studied the 2.4 mg weekly regimen, not the Ozempic ceiling. Reading a Wegovy result and expecting it from a 1 mg Ozempic dose sets up a false comparison.
How do the two products compare on dosing?
| Feature | Ozempic | Wegovy |
|---|---|---|
| Approved use | Type 2 diabetes | Chronic weight management |
| Starting dose | 0.25 mg weekly | 0.25 mg weekly |
| Maximum dose | 2 mg weekly | 2.4 mg weekly |
| Titration length | At least 16 weeks to reach 2 mg | At least 16 weeks to reach 2.4 mg |
| Active molecule | Semaglutide | Semaglutide |
Why is the first dose so small?
Because it is a foothold, not a therapy. The 0.25 mg dose gives the digestive system four weeks to adapt before the amount that does clinical work arrives. People who start too high, or move up before their stomach settles, tend to feel worse and quit sooner. The titration schedule is one of the more evidence-driven parts of the label, and skipping steps rarely speeds up results. It usually just trades a few weeks of patience for a few weeks of nausea.
What happens if you stop, and does the dose need maintaining?
This is where dosing questions turn into long-term ones. The STEP 4 trial found that people who switched to placebo after reaching the maintenance dose regained weight, while those who kept taking semaglutide continued to lose. The STEP 1 trial extension pointed the same way: much of the lost weight came back within roughly a year of stopping, and some cardiometabolic gains reversed. The practical read is that the effect depends on staying on the drug, so the maintenance dose is not a finish line.
That reality shapes cost planning more than the starting dose does, because the expense is ongoing. Some people compare an insured Ozempic prescription against cash routes, and supervised telehealth practices such as Ro, Hims and Hers, Henry Meds, and FormBlends publish flat monthly pricing that can help set expectations before committing to a maintenance regimen; one plain rundown of the schedule and what each step involves is FormBlends’ explainer on the Ozempic dose. The decision about whether continued treatment is right still belongs with a prescriber who knows the case.
What about compounded semaglutide doses?
Compounded semaglutide is prepared by a compounding pharmacy and is not an FDA-approved product. It may contain the same molecule, but it has not gone through the approval process behind the WEGOVY and OZEMPIC labels, and its dosing is not governed by those labels. That is a genuine difference, not a footnote. Anyone using a compounded version should get dosing and any titration plan directly from the prescribing clinician, because there is no approved dosing document to fall back on.
Are there other dosing forms coming?
The dosing conversation is broadening beyond weekly injections. Orforglipron, an oral small-molecule GLP-1 receptor agonist studied for obesity, was approved in 2026 for weight management and offers a daily pill rather than a weekly shot. It is a different molecule with its own dosing entirely, so it does not change Ozempic’s schedule, but it signals that the once-weekly injection is no longer the only shape these treatments take.
Key takeaways
- Ozempic starts at 0.25 mg weekly for four weeks, then steps up, capping at 2 mg.
- The low starting dose exists to reduce nausea, not to treat on its own.
- Ozempic and Wegovy share a molecule but have separate approvals and dose ceilings.
- Trial evidence shows weight tends to return after stopping, so maintenance matters.
- Compounded semaglutide is not FDA-approved and has no label-set dose.
Frequently asked questions
What is the standard Ozempic starting dose?
The label lists 0.25 mg once weekly for four weeks as a starting dose that is meant to reduce stomach side effects rather than to treat blood sugar. After that the dose usually moves to 0.5 mg weekly.
Why does the dose go up so slowly?
Slow titration exists to limit nausea, vomiting, and other digestive effects that are far more common when the dose rises quickly. The starting amount is not designed to be effective on its own.
What is the highest Ozempic dose?
The Ozempic label tops out at 2 mg once weekly. Higher weekly semaglutide doses used for weight management belong to a separate approved product, Wegovy, not to Ozempic.
Is Ozempic dosed the same for weight loss as for diabetes?
Ozempic is approved for type 2 diabetes, not weight management. The semaglutide product approved for weight loss is Wegovy, which uses its own titration schedule up to 2.4 mg weekly.
What happens if a weekly dose is missed?
The prescribing information gives specific timing rules based on how many days are left before the next scheduled dose. Those rules should come from the label and the prescriber, not from guesswork.
